The Pharmaceuticals Export Promotion Council of India (Pharmexcil), in collaboration with the Embassy of India in Armenia, is aiming to fortify trade relations and tap into the burgeoning pharmaceutical market in Armenia.
In order to initiate the collaboration, Pharmexcil is all set to host a webinar titled “Armenia-India Collaborative Opportunities in the Pharmaceutical Sector” on May 17, 2024.
Armenia, a promising market within the Commonwealth of Independent States (CIS) region, imported pharmaceuticals worth USD 213.7 million in 2022. The market is projected to grow to USD 548.4 million by 2027, reflecting a compound annual growth rate (CAGR) of 10.4%.
Scheduled to commence at 17:30 IST (16:00 Armenian Time), the webinar will offer in-depth insights into Armenia’s regulatory framework, enabling Indian pharmaceutical companies to better navigate and engage with the Armenian market.
The webinar will feature experts from Armenia discussing regulatory aspects and recent healthcare reforms aimed at Universal Health Insurance. This will equip participants with critical knowledge to leverage opportunities in the expanding Armenian market.
Uday Bhaskar, director general (DG) of Pharmexcil, emphasized the significance of this event, stating, “I urge member companies to take advantage of this opportunity to explore and expand their presence in the Armenian health sector. The insights gained from this webinar will be invaluable for enhancing our exports to Armenia.”
A Q&A session will follow the presentations, allowing participants to interact directly with Armenian stakeholders, fostering potential business collaborations.
